Cargando…
Modifying Effect of the Interleukin-18 Level on the Association between BDNF Methylation and Long-Term Cardiovascular Outcomes in Patients with Acute Coronary Syndrome
This study investigated the potential modifying effects of the level of the serum interleukin-18 (IL-18) on the association between BDNF methylation status and long-term cardiovascular outcomes in patients with acute coronary syndrome (ACS). Hospitalized ACS patients were recruited sequentially from...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738340/ https://www.ncbi.nlm.nih.gov/pubmed/36499595 http://dx.doi.org/10.3390/ijms232315270 |
_version_ | 1784847516715450368 |
---|---|
author | Choi, Wonsuk Kang, Hee-Ju Kim, Ju-Wan Kim, Hee Kyung Kang, Ho-Cheol Kim, Sung-Wan Kim, Jung-Chul Ahn, Youngkeun Jeong, Myung Ho Kim, Jae-Min |
author_facet | Choi, Wonsuk Kang, Hee-Ju Kim, Ju-Wan Kim, Hee Kyung Kang, Ho-Cheol Kim, Sung-Wan Kim, Jung-Chul Ahn, Youngkeun Jeong, Myung Ho Kim, Jae-Min |
author_sort | Choi, Wonsuk |
collection | PubMed |
description | This study investigated the potential modifying effects of the level of the serum interleukin-18 (IL-18) on the association between BDNF methylation status and long-term cardiovascular outcomes in patients with acute coronary syndrome (ACS). Hospitalized ACS patients were recruited sequentially from 2006 to 2012. At baseline, the IL-18 level and BDNF methylation status were evaluated in 969 patients who were followed for major adverse cardiac events (MACEs) for 5–12 years, until 2017 or death. The time to first composite or individual MACE was compared between individuals with lower and higher average BDNF methylation levels (in the low- and high-IL-18 groups, respectively) using a Cox proportional hazards model. After adjusting for potential covariates, the modifying effects of IL-18 and average BDNF methylation levels on the initial composite and individual MACEs were examined. In the high-IL-18 group, but not in the low-IL-18 group, a higher average BDNF methylation level was associated with increases in composite MACEs (HR (95% CI) = 2.15 (1.42–3.26)), all-cause mortality (HR (95% CI) = 1.89 (1.11–3.22)), myocardial infarction (HR (95% CI) = 1.98 (1.07–3.67)), and percutaneous coronary intervention (HR (95% CI) = 1.81 (1.01–3.23)), independent of confounding variables. The interaction effect between the IL-18 and average BDNF methylation levels on composite MACEs (p = 0.019) and myocardial infarction (p = 0.027) was significant after adjusting for covariates. Analysis of BDNF methylation status and IL-18 levels may help identify ACS patients who are most likely to have adverse clinical outcomes. |
format | Online Article Text |
id | pubmed-9738340 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97383402022-12-11 Modifying Effect of the Interleukin-18 Level on the Association between BDNF Methylation and Long-Term Cardiovascular Outcomes in Patients with Acute Coronary Syndrome Choi, Wonsuk Kang, Hee-Ju Kim, Ju-Wan Kim, Hee Kyung Kang, Ho-Cheol Kim, Sung-Wan Kim, Jung-Chul Ahn, Youngkeun Jeong, Myung Ho Kim, Jae-Min Int J Mol Sci Article This study investigated the potential modifying effects of the level of the serum interleukin-18 (IL-18) on the association between BDNF methylation status and long-term cardiovascular outcomes in patients with acute coronary syndrome (ACS). Hospitalized ACS patients were recruited sequentially from 2006 to 2012. At baseline, the IL-18 level and BDNF methylation status were evaluated in 969 patients who were followed for major adverse cardiac events (MACEs) for 5–12 years, until 2017 or death. The time to first composite or individual MACE was compared between individuals with lower and higher average BDNF methylation levels (in the low- and high-IL-18 groups, respectively) using a Cox proportional hazards model. After adjusting for potential covariates, the modifying effects of IL-18 and average BDNF methylation levels on the initial composite and individual MACEs were examined. In the high-IL-18 group, but not in the low-IL-18 group, a higher average BDNF methylation level was associated with increases in composite MACEs (HR (95% CI) = 2.15 (1.42–3.26)), all-cause mortality (HR (95% CI) = 1.89 (1.11–3.22)), myocardial infarction (HR (95% CI) = 1.98 (1.07–3.67)), and percutaneous coronary intervention (HR (95% CI) = 1.81 (1.01–3.23)), independent of confounding variables. The interaction effect between the IL-18 and average BDNF methylation levels on composite MACEs (p = 0.019) and myocardial infarction (p = 0.027) was significant after adjusting for covariates. Analysis of BDNF methylation status and IL-18 levels may help identify ACS patients who are most likely to have adverse clinical outcomes. MDPI 2022-12-03 /pmc/articles/PMC9738340/ /pubmed/36499595 http://dx.doi.org/10.3390/ijms232315270 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Choi, Wonsuk Kang, Hee-Ju Kim, Ju-Wan Kim, Hee Kyung Kang, Ho-Cheol Kim, Sung-Wan Kim, Jung-Chul Ahn, Youngkeun Jeong, Myung Ho Kim, Jae-Min Modifying Effect of the Interleukin-18 Level on the Association between BDNF Methylation and Long-Term Cardiovascular Outcomes in Patients with Acute Coronary Syndrome |
title | Modifying Effect of the Interleukin-18 Level on the Association between BDNF Methylation and Long-Term Cardiovascular Outcomes in Patients with Acute Coronary Syndrome |
title_full | Modifying Effect of the Interleukin-18 Level on the Association between BDNF Methylation and Long-Term Cardiovascular Outcomes in Patients with Acute Coronary Syndrome |
title_fullStr | Modifying Effect of the Interleukin-18 Level on the Association between BDNF Methylation and Long-Term Cardiovascular Outcomes in Patients with Acute Coronary Syndrome |
title_full_unstemmed | Modifying Effect of the Interleukin-18 Level on the Association between BDNF Methylation and Long-Term Cardiovascular Outcomes in Patients with Acute Coronary Syndrome |
title_short | Modifying Effect of the Interleukin-18 Level on the Association between BDNF Methylation and Long-Term Cardiovascular Outcomes in Patients with Acute Coronary Syndrome |
title_sort | modifying effect of the interleukin-18 level on the association between bdnf methylation and long-term cardiovascular outcomes in patients with acute coronary syndrome |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738340/ https://www.ncbi.nlm.nih.gov/pubmed/36499595 http://dx.doi.org/10.3390/ijms232315270 |
work_keys_str_mv | AT choiwonsuk modifyingeffectoftheinterleukin18levelontheassociationbetweenbdnfmethylationandlongtermcardiovascularoutcomesinpatientswithacutecoronarysyndrome AT kangheeju modifyingeffectoftheinterleukin18levelontheassociationbetweenbdnfmethylationandlongtermcardiovascularoutcomesinpatientswithacutecoronarysyndrome AT kimjuwan modifyingeffectoftheinterleukin18levelontheassociationbetweenbdnfmethylationandlongtermcardiovascularoutcomesinpatientswithacutecoronarysyndrome AT kimheekyung modifyingeffectoftheinterleukin18levelontheassociationbetweenbdnfmethylationandlongtermcardiovascularoutcomesinpatientswithacutecoronarysyndrome AT kanghocheol modifyingeffectoftheinterleukin18levelontheassociationbetweenbdnfmethylationandlongtermcardiovascularoutcomesinpatientswithacutecoronarysyndrome AT kimsungwan modifyingeffectoftheinterleukin18levelontheassociationbetweenbdnfmethylationandlongtermcardiovascularoutcomesinpatientswithacutecoronarysyndrome AT kimjungchul modifyingeffectoftheinterleukin18levelontheassociationbetweenbdnfmethylationandlongtermcardiovascularoutcomesinpatientswithacutecoronarysyndrome AT ahnyoungkeun modifyingeffectoftheinterleukin18levelontheassociationbetweenbdnfmethylationandlongtermcardiovascularoutcomesinpatientswithacutecoronarysyndrome AT jeongmyungho modifyingeffectoftheinterleukin18levelontheassociationbetweenbdnfmethylationandlongtermcardiovascularoutcomesinpatientswithacutecoronarysyndrome AT kimjaemin modifyingeffectoftheinterleukin18levelontheassociationbetweenbdnfmethylationandlongtermcardiovascularoutcomesinpatientswithacutecoronarysyndrome |